Conjugation to PEG as a Strategy to Limit the Uptake of Drugs by the Placenta: Potential Applications for Drug Administration in Pregnancy. (2022)
Attributed to:
Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.1c00498
PubMed Identifier: 34842438
Publication URI: http://europepmc.org/abstract/MED/34842438
Type: Journal Article/Review
Volume: 19
Parent Publication: Molecular pharmaceutics
Issue: 1
ISSN: 1543-8384